Clinical trials in Denmark – page 57

Denmark conducts extensive research in oncology, focusing on a wide range of solid tumors and hematological malignancies. Clinical trials investigate treatments for breast cancer, lung cancer, colorectal cancer, and melanoma, often targeting specific genetic mutations such as KRAS G12C, HER2, and BRAF V600E. Research in hematological cancers includes studies on acute myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, and various lymphomas.

• Advanced solid tumors with specific genetic alterations including RAS mutations and HER2 expression
• Hematological malignancies such as acute lymphoblastic leukemia, non-Hodgkin lymphoma, and myelodysplastic syndromes
• Targeted therapies and immunotherapies for metastatic cancers
• Pediatric oncology including neuroblastoma, medulloblastoma, and rare CNS tumors

These trials aim to improve survival rates and quality of life through novel therapeutic approaches, personalized medicine strategies, and combination therapies. Many studies focus on identifying biomarkers to guide treatment decisions and evaluate responses to targeted agents.

Research in cardiovascular diseases represents a major focus area, with trials examining conditions such as heart failure, atrial fibrillation, acute myocardial infarction, and atherosclerotic cardiovascular disease. Studies investigate both acute interventions and long-term management strategies for patients with various cardiac conditions.

• Heart failure with reduced and preserved ejection fraction
• Acute coronary syndromes including STEMI and NSTEMI
• Atrial fibrillation management and stroke prevention
• Hypertrophic cardiomyopathy and other cardiomyopathies

Trials evaluate novel pharmacological interventions, device therapies, and surgical approaches to reduce cardiovascular mortality and improve patient outcomes. Research also addresses complications following cardiac surgery and explores preventive strategies for high-risk populations.

Denmark conducts significant research in autoimmune diseases and inflammatory conditions, including rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus, and multiple sclerosis. Trials focus on novel biologics and targeted therapies to achieve disease remission and improve quality of life.

• Crohn's disease and ulcerative colitis with moderate to severe activity
• Rheumatoid arthritis and psoriatic arthritis
• Systemic lupus erythematosus and lupus nephritis
• Multiple sclerosis including relapsing-remitting and progressive forms

Research emphasizes personalized treatment approaches, biomarker-guided therapy, and strategies to minimize treatment-related toxicity while maintaining disease control. Studies also investigate the underlying mechanisms of autoimmune conditions to develop more effective interventions.

Clinical trials in neurology address a diverse range of conditions including neurodegenerative diseases, neuromuscular disorders, and epilepsy. Research focuses on Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and various forms of muscular dystrophy.

• Alzheimer's disease and mild cognitive impairment
• Duchenne and Becker muscular dystrophy
• Spinal muscular atrophy and other motor neuron diseases
• Refractory epilepsy and status epilepticus

Trials evaluate disease-modifying therapies, symptomatic treatments, and gene therapies aimed at slowing disease progression and improving neurological function. Pediatric neurology research includes rare genetic conditions and developmental disorders.

Research in metabolic diseases encompasses diabetes mellitus, obesity, dyslipidemia, and rare metabolic conditions. Trials investigate novel therapeutic approaches for type 2 diabetes, weight management, and metabolic complications including non-alcoholic steatohepatitis.

• Type 2 diabetes and diabetic complications including nephropathy and neuropathy
• Obesity management and metabolic syndrome
• Familial hypercholesterolemia and elevated lipoprotein(a)
• Rare metabolic disorders such as phenylketonuria and glycogen storage diseases

Studies aim to improve glycemic control, reduce cardiovascular risk, and address metabolic complications through pharmacological interventions and lifestyle modifications. Research also explores the intersection of metabolic disease with cardiovascular and renal outcomes.

Clinical trials in respiratory medicine focus on asthma, chronic obstructive pulmonary disease, cystic fibrosis, and interstitial lung diseases. Research investigates both common chronic conditions and rare pulmonary disorders.

• Severe asthma and eosinophilic asthma phenotypes
• COPD with frequent exacerbations
• Idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
• Cystic fibrosis across different age groups

Trials evaluate targeted biologics, small molecule therapies, and gene modifiers to improve lung function, reduce exacerbations, and enhance quality of life. Pediatric respiratory research includes studies on bronchiolitis and primary ciliary dyskinesia.

Research in nephrology and urology addresses chronic kidney disease, glomerular diseases, and bladder cancer. Trials investigate treatments for IgA nephropathy, diabetic kidney disease, and focal segmental glomerulosclerosis.

• Chronic kidney disease with proteinuria
• IgA nephropathy and membranous nephropathy
• Non-muscle invasive and muscle invasive bladder cancer
• Polycystic kidney disease

Studies aim to slow disease progression, reduce proteinuria, and preserve renal function through novel pharmacological approaches. Urological research includes trials on bladder cancer immunotherapy and targeted therapies for advanced disease.

Clinical trials in dermatology focus on atopic dermatitis, psoriasis, hidradenitis suppurativa, and other inflammatory skin conditions. Research evaluates biologics and targeted therapies for moderate to severe disease.

• Moderate to severe atopic dermatitis in adults and children
• Plaque psoriasis and psoriatic arthritis
• Hidradenitis suppurativa with inadequate response to conventional therapy
• Chronic spontaneous urticaria and prurigo nodularis

Trials aim to achieve disease clearance, reduce symptoms, and improve quality of life through novel immunomodulatory agents and targeted biologics. Research also addresses rare skin conditions and genetic disorders affecting the skin.

Research in infectious diseases includes studies on HIV infection, bacterial infections, viral infections, and vaccine development. Trials investigate novel antiretroviral therapies, antibiotics for resistant organisms, and preventive strategies.

• HIV-1 infection treatment and pre-exposure prophylaxis
• Clostridioides difficile infection and recurrence prevention
• Vaccine studies for influenza, RSV, and meningococcal disease
• Antimicrobial resistance and novel antibiotic therapies

Studies aim to improve treatment outcomes, prevent transmission, and develop effective vaccines against emerging pathogens. Research also addresses hospital-acquired infections and antimicrobial stewardship.

Denmark participates in research on rare diseases and genetic disorders, including lysosomal storage diseases, inherited metabolic conditions, and rare neuromuscular disorders. Trials often involve gene therapies and enzyme replacement treatments.

• Pompe disease, Fabry disease, and other lysosomal storage disorders
• Hereditary transthyretin amyloidosis
• Achondroplasia and skeletal dysplasias
• Friedreich's ataxia and spinocerebellar ataxias

Research focuses on disease-modifying therapies, symptom management, and improving quality of life for patients with these challenging conditions. Many studies involve international collaborations due to the rarity of these diseases.

Clinical trials in gastroenterology address inflammatory bowel disease, liver diseases, and gastrointestinal cancers. Research includes studies on non-alcoholic steatohepatitis, primary biliary cholangitis, and primary sclerosing cholangitis.

• Moderately to severely active Crohn's disease and ulcerative colitis
• Non-alcoholic steatohepatitis and alcohol-related liver disease
• Primary sclerosing cholangitis and primary biliary cholangitis
• Esophageal and gastric adenocarcinomas

Trials evaluate novel anti-inflammatory agents, antifibrotic therapies, and targeted treatments for gastrointestinal malignancies. Research aims to achieve mucosal healing, prevent disease progression, and improve long-term outcomes.

Research in hematology includes studies on hemophilia, thrombocytopenia, anemia, and coagulation disorders. Trials investigate gene therapies, novel clotting factor products, and treatments for bleeding and clotting disorders.

• Hemophilia A and B with and without inhibitors
• Immune thrombocytopenia and thrombotic disorders
• Sickle cell disease and thalassemia
• Venous thromboembolism and anticoagulation management

Studies aim to improve hemostasis, reduce bleeding episodes, and develop safer anticoagulation strategies. Research also addresses rare coagulation disorders and inherited bleeding conditions.

Clinical trials in pediatrics cover a wide range of conditions including pediatric cancers, genetic disorders, autoimmune diseases, and developmental conditions. Research addresses unique challenges in treating children and adolescents.

• Pediatric acute lymphoblastic leukemia and solid tumors
• Juvenile idiopathic arthritis
• Duchenne muscular dystrophy and spinal muscular atrophy
• Autism spectrum disorder and developmental disorders

Trials evaluate age-appropriate formulations, dosing strategies, and long-term safety of treatments in pediatric populations. Research emphasizes improving outcomes while minimizing treatment-related toxicity and supporting normal development.

Research in ophthalmology focuses on age-related macular degeneration, glaucoma, retinal diseases, and inherited eye disorders. Trials investigate novel therapies to preserve vision and prevent blindness.

• Neovascular age-related macular degeneration
• Open-angle glaucoma and ocular hypertension
• Geographic atrophy and retinitis pigmentosa
• Diabetic retinopathy and macular edema

Studies evaluate anti-VEGF therapies, gene therapies, and novel surgical approaches to improve visual outcomes. Research also addresses rare inherited retinal diseases and corneal disorders.

Clinical trials in pain management and anesthesia investigate treatments for chronic pain, neuropathic pain, and postoperative pain. Research also addresses optimal anesthetic techniques and perioperative care.

• Chronic pain due to osteoarthritis and neuropathy
• Diabetic neuropathic pain and trigeminal neuralgia
• Postoperative pain management strategies
• Anesthetic dosing and safety in special populations

Trials evaluate novel analgesics, interventional techniques, and multimodal approaches to pain control. Research aims to improve pain relief while reducing opioid dependence and minimizing side effects.